Sloan Kettering’s Crisis

A Reckoning Over Industry Ties

Memorial Sloan Kettering Cancer Center in New York is re-examining conflicts of interest after articles by ProPublica and The New York Times highlighted the relationships between its staff and health care companies.

Impact of Our Reporting

Top Official at Memorial Sloan Kettering Resigns After Failing to Disclose Industry Ties

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times

September 13, 2018, 8:45 pm EDT

15 stories published since 2018

Memorial Sloan Kettering Gave Top Doctor $1.5 Million After He Was Forced to Resign Over Conflicts of Interest

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica

December 22, 2020, 2:04 pm EST
Memorial Sloan Kettering Leaders Violated Conflict-of-Interest Rules, Report Finds

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times

April 4, 2019, 3:41 pm EDT
Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica

January 11, 2019, 7:05 pm EST
Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica

January 7, 2019, 6:17 pm EST
Memorial Sloan Kettering’s Season of Turmoil

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica

December 31, 2018, 10:30 am EST
Top Cancer Doctor Resigns as Editor of Medical Journal

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica

December 19, 2018, 3:30 pm EST
Sloan Kettering Cancer Researchers Correct the Record by Revealing Company Ties

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times

October 12, 2018, 3:15 pm EDT
Memorial Sloan Kettering’s Chief Executive Resigns From Merck’s Board of Directors

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica

October 2, 2018, 4:00 pm EDT
Cancer Center’s Board Chairman Faults Top Doctor, Saying He “Crossed Lines”

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times

October 1, 2018, 7:30 pm EDT
Facing Crisis, Sloan Kettering Tells Exec to Hand Over Profits From Biotech

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica

September 29, 2018, 12:15 pm EDT
Cancer Center Switches Focus on Fundraising as Problems Mount

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times

September 25, 2018, 8:00 pm EDT
Sloan Kettering’s Cozy Deal With Start-Up Ignites a New Uproar

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times

September 20, 2018, 4:10 pm EDT
Sloan Kettering Cancer Center Orders Staff to “Do a Better Job” of Disclosing Industry Ties

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica

September 9, 2018, 4:00 pm EDT
Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times

September 8, 2018, 1:00 pm EDT